Based on a 2018 meta-analysis of 10 clinical trials, supplementation with either prebiotics or synbiotics can result in significant reductions in FPG and Hb A1c levels in T2DM patients (55). This evidence concerns the gene GSTM1 and type 2 diabetes mellitus.